Stockreport

Palisade Bio Announces Pricing of Upsized $120 Million Underwritten Public Offering of Common Stock [Yahoo! Finance]

Palisade Bio, Inc.  (PALI) 
PDF the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and [Read more]